Humacyte (HUMA) Amortizatization of Intangibles (2020 - 2025)
Humacyte (HUMA) reported Amortizatization of Intangibles of $2.0 million for Q4 2025, up 13992.86% year-over-year from N/an in Q4 2024, and up 276.53% quarter-over-quarter from $524000.0 in Q3 2025.
Humacyte (HUMA) Amortizatization of Intangibles (2020 - 2025) Analysis & Trends
Humacyte (HUMA) has 6 years of Amortizatization of Intangibles data on file, last reported at $2.0 million in Q4 2025.
- Amortizatization of Intangibles for Q4 2025 came in at $2.0 million, up 13992.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.5 million (up 7775.56% YoY), and the FY2025 annual result was $2.0 million, up 3705.66% from the prior year.
- Amortizatization of Intangibles improved to $2.0 million in Q4 2025 per HUMA's latest filing, from $524000.0 in the prior quarter.
- Over five years, Amortizatization of Intangibles peaked at $2.0 million in Q4 2025 and troughed at -$1.5 million in Q4 2023.
- A 5-year average of $378526.3 and a median of $515000.0 in 2022 frame the typical range for Amortizatization of Intangibles.
- The sharpest annual moves came in 2023 and 2025: Amortizatization of Intangibles tumbled 276.3% in 2023, then jumped 13992.86% in 2025.
- A 5-year view of Amortizatization of Intangibles shows it stood at $946000.0 in 2021, then fell by 10.36% to $848000.0 in 2022, then plunged by 276.3% to -$1.5 million in 2023, then surged by 100.94% to $14000.0 in 2024, then jumped by 13992.86% to $2.0 million in 2025.
- Business Quant data shows HUMA's Amortizatization of Intangibles at $2.0 million in Q4 2025, $524000.0 in Q3 2025, and $1.0 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Humacyte | 267.09 Mn | 218.55 Mn | -1.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.97 Mn |
| Dec 31, 2025 | 1.97 Mn |
| Sep 30, 2025 | 524,000.00 |
| Sep 30, 2025 | 524,000.00 |
| Jun 30, 2025 | 1.05 Mn |
| Jun 30, 2025 | 1.05 Mn |
| Dec 31, 2024 | 14,000.00 |
| Dec 31, 2024 | 14,000.00 |
| Sep 30, 2024 | 522,000.00 |
| Sep 30, 2024 | 522,000.00 |
| Jun 30, 2024 | -491,000.00 |
| Jun 30, 2024 | -491,000.00 |
| Mar 31, 2024 | 517,000.00 |
| Mar 31, 2024 | 517,000.00 |
| Dec 31, 2023 | -1.50 Mn |
| Dec 31, 2023 | -1.50 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Sep 30, 2023 | 1.52 Mn |
| Jun 30, 2023 | -491,000.00 |
| Jun 30, 2023 | -491,000.00 |